Ilja P Hohenfeld

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 4

Top Topics

Affordable Care Act

Chronic Rhinosinusitis

Pluripotent Stem Cells

Top Venues

Drug development and industrial pharmacy

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Martin M Sailer, Melanie Köllmer, Beatrice Masson, Fabio Fais, Ilja P Hohenfeld, Michael E Herbig, Assen K Koitschev, Sven Becker
Nasal residence time and rheological properties of a new bentonite-based thixotropic gel emulsion nasal spray - AM-301. Drug development and industrial pharmacy (2023)
Martin M Sailer, Melanie Köllmer, Beatrice Masson, Fabio Fais, Ilja P Hohenfeld, Michael E Herbig, Assen K Koitschev, Sven Becker
Nasal residence time and rheological properties of a new bentonite-based thixotropic gel emulsion nasal spray - AM-301. Drug development and industrial pharmacy 49 (1) (2023)
Martin M Sailer, Melanie Köllmer, Beatrice Masson, Fabio Fais, Ilja P Hohenfeld, Michael E Herbig, Assen K Koitschev, Sven Becker
Nasal residence time and rheological properties of a new bentonite-based thixotropic gel emulsion nasal spray - AM-301. Drug development and industrial pharmacy 49 (1) (2023)
Fabio Fais, Reda Juskeviciene, Veronica Francardo, Stéphanie Mateos, Manuela Guyard, Cécile Viollet, Samuel Constant, Massimo Borelli, Ilja P Hohenfeld
Drug-Free Nasal Spray as a Barrier against SARS-CoV-2 and Its Delta Variant: In Vitro Study of Safety and Efficacy in Human Nasal Airway Epithelia. International journal of molecular sciences 23 (7) (2022)